Moderna Says FDA Needs More Time To Review Its Covid Vaccine For Teens


Moderna had issued a statement where they had said that the FDA or the food and drug administration would need some more time in order to review the vaccine for teens developed by the company. This vaccine is for teenagers who are falling under the age group of 12 and 17. This is indeed something important in the world of the pandemic and that’s why we understand when they say that time is needed for the matter at hand.

The review is mostly being done about a disease or rather a condition called myocarditis in kids. It is a kind of inflammation of the heart muscle. It is indeed a very serious side effect of the vaccine that can happen to the people or rather the kids and no one wants that to happen.

Moderna Says FDA Needs More Time To Review Its Covid Vaccine For Teens

So the FDA is taking their time to fully check on everything along with the odds and risks and then they are going to provide the green light for the vaccine but Moderna had said that this might not be happening this year and might take some time and most probably be given the final say in the year of 2022, which is the next year.

“The company is fully committed to this case and we also believe that in order to make sure everything is clear and okay we have agreed to work closely with the FDA and we are always going to support their review. The company is also very grateful to the FDA for their diligence,” Moderna said in a statement.

While it is true that more and more vaccines are required to vaccinate such a huge population of the United States, it also must be noted that not just any vaccine can be given to anyone at any point in time. There needs to be a fully checked and safe vaccine for the people.

FDA is just doing its job and taking care of that. That’s all for now. We will surely keep you updated on the news. So make sure that you keep an eye out for it. And do make sure to stay safe!


Please enter your comment!
Please enter your name here